Received Nov 10, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| FLUX | INFLUENZA (SEASONAL) (NO BRAND NAME) | UNKNOWN MANUFACTURER | UNK | 247L3 | — |
Fever; elevated liver enzymes; chills; This non-serious case was reported by a consumer and described the occurrence of fever in a 60-year-old female patient who received Flu unspecified (Flu vaccine) (batch number 247L3, expiry date 30-JUN-2026) for prophylaxis. Concurrent medical conditions included diabetes, medullary sponge kidney, triglycerides high and anxiety. Concomitant products included semaglutide (Ozempic), hydrochlorothiazide;triamterene (Maxide), fenofibrate and bupropion. On 22-OCT-2025, the patient received Flu vaccine .5 ml. On 23-OCT-2025, 1 days after receiving Flu vaccine, the patient experienced fever (Verbatim: Fever), elevated liver enzymes (Verbatim: elevated liver enzymes) and chills (Verbatim: chills). The outcome of the fever, elevated liver enzymes and chills were resolving. It was unknown if the reporter considered the fever, elevated liver enzymes and chills to be related to Flu vaccine. It was unknown if the company considered the fever, elevated liver enzymes and chills to be related to Flu vaccine. Additional Information: GSK receipt date: 24-OCT-2025 The reporter mentioned after vaccine patient experienced fever 105, chills, elevated liver enzyme.
Anxiety; Diabetes; Medullary sponge kidney; Triglycerides high
OZEMPIC; MAXIDE; FENOFIBRATE; BUPROPION
Test Name: Body temperature; Result Unstructured Data: (Test Result:105,Unit:unknown,Normal Low:,Normal High:)